Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $3.35 billion. The enterprise value is $798.39 million.
| Market Cap | 3.35B |
| Enterprise Value | 798.39M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 201.71 million shares outstanding. The number of shares has increased by 35.44% in one year.
| Shares Outstanding | 201.71M |
| Shares Change (YoY) | +35.44% |
| Shares Change (QoQ) | +29.34% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 79.96% |
| Float | 180.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 62.56 |
| PS Ratio | 0.51 |
| Forward PS | 0.35 |
| PB Ratio | 3.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.12 |
| EV / EBITDA | 120.68 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.16 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 45.19 |
| Debt / FCF | n/a |
| Interest Coverage | -1.11 |
Financial Efficiency
Return on equity (ROE) is -5.80% and return on invested capital (ROIC) is -1.86%.
| Return on Equity (ROE) | -5.80% |
| Return on Assets (ROA) | -1.30% |
| Return on Capital (ROIC) | -1.86% |
| Revenue Per Employee | $2.72M |
| Profits Per Employee | -$22,328 |
| Employee Count | 2,400 |
| Asset Turnover | 1.64 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $2.27 million in taxes.
| Income Tax | 2.27M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +104.82% in the last 52 weeks. The beta is 1.68, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +104.82% |
| 50-Day Moving Average | 19.35 |
| 200-Day Moving Average | 12.62 |
| Relative Strength Index (RSI) | 36.28 |
| Average Volume (20 Days) | 3,991,136 |
Short Selling Information
The latest short interest is 11.64 million, so 5.77% of the outstanding shares have been sold short.
| Short Interest | 11.64M |
| Short Previous Month | 5.56M |
| Short % of Shares Out | 5.77% |
| Short % of Float | 6.45% |
| Short Ratio (days to cover) | 3.56 |
Income Statement
In the last 12 months, Oscar Health had revenue of $6.54 billion and -$53.59 million in losses. Loss per share was -$0.41.
| Revenue | 6.54B |
| Gross Profit | 1.43B |
| Operating Income | -24.69M |
| Pretax Income | -51.32M |
| Net Income | -53.59M |
| EBITDA | 6.62M |
| EBIT | -26.95M |
| Loss Per Share | -$0.41 |
Balance Sheet
The company has $2.85 billion in cash and $298.97 million in debt, giving a net cash position of $2.55 billion or $12.63 per share.
| Cash & Cash Equivalents | 2.85B |
| Total Debt | 298.97M |
| Net Cash | 2.55B |
| Net Cash Per Share | $12.63 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 5.12 |
| Working Capital | 484.37M |
Cash Flow
In the last 12 months, operating cash flow was -$52.51 million and capital expenditures -$24.15 million, giving a free cash flow of -$76.66 million.
| Operating Cash Flow | -52.51M |
| Capital Expenditures | -24.15M |
| Free Cash Flow | -76.66M |
| FCF Per Share | -$0.33 |
Margins
Gross margin is 21.86%, with operating and profit margins of -0.38% and -0.82%.
| Gross Margin | 21.86% |
| Operating Margin | -0.38% |
| Pretax Margin | -0.79% |
| Profit Margin | -0.82% |
| EBITDA Margin | 0.10% |
| EBIT Margin | -0.41% |
| FCF Margin | -1.17% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.44% |
| Shareholder Yield | -35.44% |
| Earnings Yield | -1.60% |
| FCF Yield | -2.29% |
Analyst Forecast
The average price target for Oscar Health is $19.75, which is 19.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.75 |
| Price Target Difference | 19.05% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 29.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oscar Health has an Altman Z-Score of 1.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 3 |